Navigation Links
New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
Date:1/24/2008

Coloradoans sought for study

DENVER, Jan. 24 /PRNewswire/ -- Regenerative Sciences, Inc., creator of the Regenexx(TM) procedure that uses a patient's own stem cells to regenerate bone and cartilage, has announced a new clinical study using its patent pending processes to treat tendon injuries.

The company is recruiting patients with moderate to severe tennis elbow, partial rotator cuff tears or Achilles tendon tears, and moderate to severe plantar fasciitis. This study has been sanctioned by an independent research review board and involves using the patient's own stem cells to repair and strengthen these tissues.

"We have evidence from large animal models that our stem cell procedure may help heal these chronic tendon problems without the need for surgery," said Chris Centeno, M.D., creator of Regenexx and an international expert and specialist in musculoskeletal, spinal and neurological injury.

To be considered for the Regenexx tendon study, please email Regenexx@rsihealth.net. All costs directly related to the study will be covered by the company.

The study involves harvesting the patient's own mesenchymal stem cells, growing them in a culture using the company's patent pending procedure, and then injecting these culture expanded cells into an area in need of repair.

Repair of the degenerated or injured area usually takes place in two to three months, and many patients feel better in one to three months.

About Regenerative Sciences

Founded in 2006, Regenerative Sciences is the Denver-based developer of Regenexx(TM), a breakthrough non-surgical option for people suffering from various orthopedic disorders. Regenexx is a patent-pending procedure that uses a person's own stem cells and blood growth factors to regenerate bone and cartilage.

The physicians at Regenerative Sciences are dedicated to providing the option of non-surgical joint repair to their patients. Headquartered in Colorado, they focus on delivering high quality treatment for people suffering from these often debilitating diseases. Visit http://www.Regenexx.com to learn more about benefits, research and the Regenexx procedure.


'/>"/>
SOURCE Regenerative Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
2. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
3. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
4. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
5. New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
6. Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos
7. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
8. Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. Its Only Heartburn...or is it? Chronic Heartburn a Risk Factor for Precursor to Esophageal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... pharmaceutical company focused on the development of oral drug delivery ... Israel Securities Authority to dual-list its common stock on the ... trading on the TASE on July 12, 2017 under the ... Company, it is expected that Oramed will be included in ...
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the ... The research describes the use of its AVACEN Treatment Method ... suffering from fibromyalgia. ... AVACEN Medical ... characterized by chronic widespread pain. It affects approximately 200 to 400 million ...
(Date:6/20/2017)... , June 19, 2017  Hill-Rom Holdings, Inc. (NYSE: ... call and webcast on Friday, July 28, 2017, beginning at ... Call Audio Only Dial-in information: To participate in the conference ... dial into the call at least 10 minutes prior to ... is 34090339.  Webcast: ...
Breaking Medicine Technology:
(Date:7/18/2017)... ... July 18, 2017 , ... ... commercialization, has just announced two more sessions of its “From the Helm” Webinar ... management activities. Led by David Cronin, Cognition’s CEO, the half-hour public webinars will ...
(Date:7/18/2017)... PA (PRWEB) , ... July 18, 2017 , ... An ... control excessive sweating. "Due to menopause, I have frequent hot flashes, and I suffer ... effective but inconspicuous way to keep cool while out and about." INSTA-FAN meets that ...
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... FCPX LUT ... cooler tones any media. FCPX LUT Berlin includes 60 different color-grade presets, giving FCPX ... distorted looks, vignettes and blurs to emphasize each subject, plus much more. FCPX LUT ...
(Date:7/17/2017)... Greenwich, Connecticut (PRWEB) , ... July 17, 2017 ... ... not too late for parents and camp staff to ensure children are protected ... of Lyme disease this year, children are at an increased risk not only ...
(Date:7/17/2017)... ... 17, 2017 , ... Jordan Search Consultants (JSC), a national ... for Springfield Clinic’s Chief Executive Officer (CEO) in Springfield, IL. Working with JSC ... with more than 30 years of experience, as the new CEO. , ...
Breaking Medicine News(10 mins):